| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF03165287 |
| P698 | PubMed publication ID | 12430885 |
| P2093 | author name string | Guillermo J Ruiz-Argüelles | |
| P2860 | cites work | Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases | Q33331473 |
| Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT). | Q34135678 | ||
| Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantation | Q40595159 | ||
| Outpatient supportive therapy after induction to remission therapy in adult acute myelogenous leukaemia (AML) is feasible: a multicentre study. | Q40691053 | ||
| Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens | Q43560587 | ||
| Features of the engraftment of allogeneic hematopoietic stem cells using reduced-intensity conditioning regimens | Q43792719 | ||
| Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings | Q43819622 | ||
| No cytomegalovirus-related deaths after non-ablative stem cell allografts | Q44108317 | ||
| Oupatient programs of myeloablative chemotherapy, autologous and allogeneic bone marrow transplantation | Q73291250 | ||
| Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy | Q73436821 | ||
| Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases | Q74106097 | ||
| Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia | Q74571666 | ||
| SIMPLIFICATION, NOT DEMYSTIFICATION NOR TRIVIALIZATION OF STEM CELL TRANSPLANTATION | Q74622989 | ||
| Non-cryopreserved peripheral blood stem cells autotransplants for hematological malignancies can be performed entirely on an outpatient basis | Q74774018 | ||
| Engraftment of HLA-matched sibling hematopoietic stem cells after immunosuppressive conditioning regimen in patients with hematologic neoplasias | Q77607289 | ||
| 'The Mexican approach' to conduct NST | Q77711557 | ||
| Follow up of hemopoietic chimerism in individuals given allogeneic hemopoietic stem cell allografts using an immunosuppressive, non-myeloablative conditioning regimen: a prospective study in a single institution | Q78400364 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 376-379 | |
| P577 | publication date | 2002-08-01 | |
| P1433 | published in | International Journal of Hematology | Q6051416 |
| P1476 | title | Allogeneic stem cell transplantation using non-myeloablative conditioning regimens: results of the Mexican approach | |
| P478 | volume | 76 Suppl 1 |
| Q38376686 | A Feasibility Study of the Full Outpatient Conduction of Hematopoietic Transplants in Persons with Multiple Sclerosis Employing Autologous Non-Cryopreserved Peripheral Blood Stem Cells |
| Q63241100 | Allogeneic Hematopoietic Stem Cell Transplantation with Non-Myeloablative Conditioning in Patients with Acute Myelogenous Leukemia Eligible for Conventional Allografting: A Prospective Study |
| Q50757515 | Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. |
| Q35345538 | Cost structure and clinical outcome of a stem cell transplantation program in a developing country: the experience in northeast Mexico |
| Q44440137 | Decreased Transfusion Requirements in Patients Given Stem Cell Allografts Using a Non-myeloablative Conditioning Regimen: A Single Institution Experience |
| Q40448975 | Outpatient allografting using non-myeloablative conditioning: the Mexican experience. |
| Q48018762 | Reduced-intensity stem cell transplantation in children and adolescents: the Mexican experience |
| Q81247610 | Significance of one human leukocyte antigen mismatch on outcome of nonmyeloablative allogeneic stem cell transplantation from related donors using the Mexican schedule |
| Q73613431 | The Mexican approach to conduct nonmyeloablative stem cell transplantation should not be overlooked |
| Q46772662 | The early referral for reduced-intensity stem cell transplantation in patients with Ph1 (+) chronic myelogenous leukemia in chronic phase in the imatinib era: results of the Latin American Cooperative Oncohematology Group (LACOHG) prospective, multi |
| Q36090213 | The hope and the reality of reduced intensity transplants in children with malignant diseases |
Search more.